NYSEAMERICAN:IBO Impact Biomedical Q3 2026 Earnings Results & Report $4.26 -0.08 (-1.73%) As of 02:17 PM Eastern This is a fair market value price provided by Massive. Learn more. Impact Biomedical reported Q3 2026 earnings on November 9, 2026. The company reported EPS of -$0.08, while revenue was $21 thousand. Research:ProfileEarnings History Earnings Announcement Details QuarterQ3 2026Report DateNovember 9, 2026TimeAfter Market ClosesConference Call7:00 AM ET Impact Biomedical EPS ResultsActual EPS-$0.08Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AImpact Biomedical Revenue ResultsActual Revenue$21 thousandExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Impact Biomedical Q3 2026 Earnings FAQ Did Impact Biomedical beat earnings estimates for Q3 2026? Impact Biomedical (NYSEAMERICAN:IBO) reported earnings of -$0.08 per share for Q3 2026. The report was announced on Monday, November 9, 2026. What was Impact Biomedical's revenue for Q3 2026? Impact Biomedical reported revenue of $21 thousand for Q3 2026. Impact Biomedical Earnings HeadlinesImpact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed ...November 3, 2026 | finance.yahoo.comImpact BioMedical advances merger with Zoar LimitedSeptember 17, 2026 | tipranks.comEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 10 at 1:00 AM | Behind the Markets (Ad)Impact Biomedical Files Form F-4 For Proposed Zoar Business CombinationSeptember 16, 2026 | rttnews.comImpact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)September 16, 2026 | finance.yahoo.comImpact Biomedical Inc. Announces Filing of F-4 Registration Statement for Proposed Business Combination with Zoar LimitedSeptember 16, 2026 | quiverquant.comQSee More Impact Biomedical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Impact Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Impact Biomedical and other key companies, straight to your email. Email Address About Impact BiomedicalImpact Biomedical (NYSEAMERICAN:IBO), Inc. is a biotechnology company focused on developing biomedical technologies and products intended to address public-health and healthcare needs. Its activities have included research into antiviral, antimicrobial, immunomodulatory and other therapeutic applications. The company has been associated with the development of Equivir, an antiviral technology described as having potential broad-spectrum applications. Impact BioMedical has also pursued intellectual property and product-development opportunities in areas such as infectious disease prevention, immune support and related biomedical solutions. Impact BioMedical is affiliated with DSS, Inc., a diversified holding company with interests in healthcare and other industries. Publicly available information about the company’s current commercial operations, geographic markets and executive leadership is limited, and its development programs may be subject to ongoing research, regulatory review and commercialization efforts.View Impact Biomedical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles DraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Wall Street May Be Making a Big Mistake With monday.com StockCloudflare's 20% Sell-Off May Have Created an Opening for InvestorsMarketBeat Week in Review – 11/2 - 11/6 Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
